BRPI0520830A2 - solid pharmaceutical dosage form, method of subdividing a solid pharmaceutical dosage form, method of administering a portion of an active subunit of a solid pharmaceutical dosage form, method of administering an active pharmaceutical ingredient that is present within an active subunit of a solid pharmaceutical dosage form and method of producing a solid pharmaceutical dosage form - Google Patents

solid pharmaceutical dosage form, method of subdividing a solid pharmaceutical dosage form, method of administering a portion of an active subunit of a solid pharmaceutical dosage form, method of administering an active pharmaceutical ingredient that is present within an active subunit of a solid pharmaceutical dosage form and method of producing a solid pharmaceutical dosage form

Info

Publication number
BRPI0520830A2
BRPI0520830A2 BRPI0520830-0A BRPI0520830A BRPI0520830A2 BR PI0520830 A2 BRPI0520830 A2 BR PI0520830A2 BR PI0520830 A BRPI0520830 A BR PI0520830A BR PI0520830 A2 BRPI0520830 A2 BR PI0520830A2
Authority
BR
Brazil
Prior art keywords
dosage form
pharmaceutical dosage
solid pharmaceutical
active
administering
Prior art date
Application number
BRPI0520830-0A
Other languages
Portuguese (pt)
Inventor
Lawrence Solomon
Original Assignee
Accu Break Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accu Break Technologies Inc filed Critical Accu Break Technologies Inc
Publication of BRPI0520830A2 publication Critical patent/BRPI0520830A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

FORMA DE DOSAGEM FARMACêUTICA SóLIDA, MéTODO DE SUBDIVIDIR UMA FORMA DE DOSAGEM FARMACêUTICA SóLIDA, MéTODO DE ADMINISTRAçãO DE UMA PARTE DE UMA SUBUNIDADE ATIVA DE UMA FORMA DE DOSAGEM FARMACêUTICA SóLIDA, MéTODO DE ADMINISTRAçãO DE UM INGREDIENTE FARMACêUTICO ATIVO QUE ESTA PRESENTE DENTRO DE UMA SUBUNIDADE ATIVA DE UMA FORMA DE DOSAGEM FARMACêUTICA SóLIDA E MéTODO DE PRODUçãO DE UMA FORMA DE DOSAGEM FARMACêUTICA SóLIDA. Trata-se de uma forma de dosagem farmacêutica que é um agregado ligado de maneira adesiva de subunidades pré-formadas que podem ser convenientemente decompostas em partes menores.METHOD OF SOLID PHARMACEUTICAL DOSAGE, METHOD OF SUBDIVING A SOLID PHARMACEUTICAL DOSAGE METHOD, METHOD OF ADMINISTRATION OF A PART OF AN ACTIVE SUBUNIT, METHOD OF ADMINISTRATIVE ADMINISTRATIVE DEMAND OF A SOLID PHARMACEUTICAL DOSAGE FORM AND METHOD OF PRODUCTION OF A SOLID PHARMACEUTICAL DOSAGE FORM. It is a pharmaceutical dosage form which is an adhesive bonded aggregate of preformed subunits which may conveniently be broken down into smaller parts.

BRPI0520830-0A 2005-12-30 2005-12-30 solid pharmaceutical dosage form, method of subdividing a solid pharmaceutical dosage form, method of administering a portion of an active subunit of a solid pharmaceutical dosage form, method of administering an active pharmaceutical ingredient that is present within an active subunit of a solid pharmaceutical dosage form and method of producing a solid pharmaceutical dosage form BRPI0520830A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/047499 WO2007078290A1 (en) 2005-12-30 2005-12-30 Adhesively bonded dosage form

Publications (1)

Publication Number Publication Date
BRPI0520830A2 true BRPI0520830A2 (en) 2009-05-19

Family

ID=38228526

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520830-0A BRPI0520830A2 (en) 2005-12-30 2005-12-30 solid pharmaceutical dosage form, method of subdividing a solid pharmaceutical dosage form, method of administering a portion of an active subunit of a solid pharmaceutical dosage form, method of administering an active pharmaceutical ingredient that is present within an active subunit of a solid pharmaceutical dosage form and method of producing a solid pharmaceutical dosage form

Country Status (8)

Country Link
EP (1) EP1965772A1 (en)
JP (1) JP2009522259A (en)
CN (1) CN101370483A (en)
AU (1) AU2005339699A1 (en)
BR (1) BRPI0520830A2 (en)
CA (1) CA2635566A1 (en)
IL (1) IL192500A0 (en)
WO (1) WO2007078290A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2962647B1 (en) * 2010-07-19 2013-05-24 Duo Ge DEVICE AND INSTALLATION FOR ASSEMBLING AT LEAST TWO MEDICINAL CAPSULES BY COLLAGE
US10363220B2 (en) 2015-06-03 2019-07-30 Triastek, Inc. Compartmented pharmaceutical dosage forms
CN113081991B (en) * 2015-06-03 2022-07-15 南京三迭纪医药科技有限公司 Pharmaceutical dosage forms and uses thereof
KR20190107712A (en) 2017-01-26 2019-09-20 트리아스텍 인코포레이티드 Dosage forms of controlled release at specific gastrointestinal sites
CN116270513A (en) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 A compound oral pharmaceutical dosage form containing fixed dose of ADHD non-agonist and ADHD agonist

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009896A (en) * 1989-10-04 1991-04-23 Akzo N.V. Multi-fractionable tablet structure
JPH069375A (en) * 1992-04-10 1994-01-18 Takeda Chem Ind Ltd Dividable connected tablet
JP3048815B2 (en) * 1993-12-27 2000-06-05 協和醗酵工業株式会社 Method of processing tablet dividing line using laser beam
GB0027471D0 (en) * 2000-11-08 2000-12-27 Smithkline Beecham Plc Processes
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AU2002354497A1 (en) * 2001-12-19 2003-06-30 Sanwa Kagaku Kenkyusho Co., Ltd Release control type formed product
PE20060003A1 (en) * 2004-03-12 2006-03-01 Smithkline Beecham Plc POLYMERIC PHARMACEUTICAL FORMULATION FOR INJECTION MOLDING
CA2566310C (en) * 2004-05-21 2014-05-13 Lawrence Solomon Scored pharmaceutical tablets comprising a plurality of segments
JP5046501B2 (en) * 2005-08-18 2012-10-10 帝人ファーマ株式会社 Tablets that hold multiple drugs separately

Also Published As

Publication number Publication date
CA2635566A1 (en) 2007-07-12
JP2009522259A (en) 2009-06-11
EP1965772A1 (en) 2008-09-10
AU2005339699A1 (en) 2007-07-12
CN101370483A (en) 2009-02-18
WO2007078290A1 (en) 2007-07-12
IL192500A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
BR112013022044A2 (en) chewable mouth absorption vehicle
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
EA200702522A1 (en) SYSTEM OF DELIVERY OF MEDICINES IN THE CAVITY OF THE MOUTH AND METHODS OF ITS APPLICATION
BRPI0520830A2 (en) solid pharmaceutical dosage form, method of subdividing a solid pharmaceutical dosage form, method of administering a portion of an active subunit of a solid pharmaceutical dosage form, method of administering an active pharmaceutical ingredient that is present within an active subunit of a solid pharmaceutical dosage form and method of producing a solid pharmaceutical dosage form
DE602007007991D1 (en) SMALL VOLUME, ORAL, TRANSMUCOSAL DOSAGE FORMS WITH SUFENTANIL FOR PAIN TREATMENT
MX2007002898A (en) Tablets with site time-controlled gastrointestinal release of active ingredient.
HK1128230A1 (en) Dosage forms for administering combinations of drugs
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
WO2008027350A3 (en) Acetaminophen pharmaceutical compositions
UY30333A1 (en) USE OF FLIBANSERINE FOR THE TREATMENT OF SEXUAL DESIRE POSMENOPAUSIC DISORDERS
WO2012010669A3 (en) Medicinal drug for oral administration comprising a mixture of silodosin and a basic copolymer
AR057946A1 (en) FORMULATION OF SUSTAINED RELEASE ZONISAMIDE
MXPA06011467A (en) Active substance combination comprising a carbinol combined to at least an nsaid.
EA200700484A1 (en) PHARMACEUTICAL COMPOSITION OF TLTERODIN WITH PROLONGED DELIVERY
MA32386B1 (en) Pharmaceutical dosage form for immediate release of indolimone derivative
WO2007047372A3 (en) Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
MX2011011829A (en) Composition for sustained drug delivery comprising geopolymeric binder.
TN2011000651A1 (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine their preparation and their therapeutic application
PT2131810E (en) Oral administration of a calcitonin
EP1488807A4 (en) Remedies for sex hormone-dependent disease
BRPI0514701A (en) use of a selective estrogen receptor modulator, or an isomer, isomer mixture, metabolite or a pharmaceutically acceptable salt thereof
ECSP045242A (en) Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity
ATE410152T1 (en) THERAPEUTIC SYSTEM WITH AMOXICILLIN AND CLAVULANIC ACID
EA200901188A1 (en) ORGANOLEPTICALLY ACCEPTABLE DOSED MEDICINAL FORMS OF THE INDOLL AGONISTS OF SEROTONIN RECEPTORS FOR ORAL APPLICATION AND METHODS OF THEIR APPLICATION

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.